GRN额颞叶痴呆患者脑萎缩初始侧与临床特征及疾病进展的关联
该研究基于前瞻性GENFI队列的回顾性分析,纳入399名参与者,评估GRN致额颞叶痴呆(FTD-GRN)的疾病进展是否取决于脑萎缩初始侧,并探讨脑不对称作为生物标志物的潜力。症状携带者脑不对称指数显著高于非携带者及症状前携带者,右侧GRN患者在基线时疾病严重程度更高但年恶化程度更低,脑不对称可在症状出现前10.4年被发现。
要点
- 症状性GRN携带者脑不对称指数11.6,显著高于非携带者1.0和症状前携带者1.0(p均<0.001)。
- 右侧GRN患者基线疾病严重程度更高(β=6.9),但年恶化程度更低(β=-1.5),与左侧GRN患者相比。
- 脑不对称可在GRN携带者症状出现前10.4年被发现(标准差异0.85)。
核心结论
- FTD-GRN以不对称方式影响大脑半球,根据起病侧形成两种解剖不对称模式。
- 这两种解剖不对称模式表现出不同的症状、首次就诊时的严重程度和不同的疾病进程。
- 结果提示脑不对称可能是GRN携带者转化的潜在生物标志物。
研究设计与样本
- 对前瞻性遗传性额颞叶痴呆倡议(GENFI)队列研究数据的回顾性分析。
- GENFI招募携带或面临携带致FTD致病性变异风险的个体,参与者每年接受标准化临床和神经心理学评估、MRI及血液样本检测。
- 共纳入399名参与者(平均年龄49.7岁,59%女性),包括63名症状性携带者、177名症状前携带者和159名非携带者。
- 生成脑MRI不对称指数以表征FTD-GRN参与者或高危者的脑不对称,根据不对称侧将症状性GRN患者分类为右侧GRN或左侧GRN并比较临床特征和疾病进展。
- 生成广义相加模型研究不对称指数在携带者和非携带者中的演变,并与基于体积值和血浆神经丝轻链的模型比较。
主要发现
- 症状性携带者脑不对称指数为11.6,高于非携带者的1.0(p<0.001)和症状前携带者的1.0(p<0.001)。
- 大多数症状性携带者可分类为右侧GRN(n=21)或左侧GRN(n=36)。
- 右侧GRN患者基线疾病严重程度高于左侧GRN患者(β=6.9,95%CI 2.4-11.0,p=0.003),但年恶化程度低于左侧GRN患者(β=-1.5,95%CI -2.7至-0.31,p=0.015)。
- 脑不对称可在GRN携带者症状出现前10.4年被发现(标准差异0.85,CI 0.01-1.68)。
关键数值与推荐
- 症状性携带者脑不对称指数11.6 vs 非携带者1.0(p<0.001)vs 症状前携带者1.0(p<0.001)。
- 右侧GRN患者基线疾病严重程度β=6.9(95%CI 2.4-11.0,p=0.003),年恶化β=-1.5(95%CI -2.7至-0.31,p=0.015),均以左侧GRN为参照。
- 脑不对称出现于症状前10.4年(标准差异0.85,CI 0.01-1.68)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Pathogenic variants in the GRN gene cause frontotemporal dementia (FTD-GRN) with marked brain asymmetry. This study aims to assess whether the disease progression of FTD-GRN depends on the initial side of the atrophy. We also investigated the potential use of brain asymmetry as a biomarker of the disease. METHODS: Retrospective examination of data from the prospective Genetic Frontotemporal Initiative (GENFI) cohort study that recruits individuals who carry or were at risk of carrying a pathogenic variant causing FTD. GENFI participants underwent a standardized clinical and neuropsychological assessment, MRI, and a blood sample test yearly. We generated an asymmetry index for brain MRI to characterize brain asymmetry in participants with or at risk of FTD-GRN. Depending on the side of the asymmetry, we classified symptomatic GRN patients as right-GRN or left-GRN and compared their clinical features and disease progression. We generated generalized additive models to study how the asymmetry index evolves in carriers and noncarriers and compare its models with others created with volumetric values and plasma neurofilament light chain. RESULTS: A total of 399 participants (mean age 49.7 years, 59% female) were included (63 symptomatic carriers, 177 presymptomatic carriers, and 159 noncarriers). Symptomatic carriers showed higher brain asymmetry (11.6) than noncarriers (1.0, p < 0.001) and presymptomatic carriers (1.0, p < 0.001), making it possible to classify most of them as right-GRN (n = 21) or left-GRN (n = 36). Patients with right-GRN showed more disease severity at baseline (β = 6.9, 95% CI 2.4-11.0, p = 0.003) but a lower deterioration by year (β = -1.5, 95% CI -2.7 to -0.31, p = 0.015) than patients with left-GRN. Brain asymmetry could be found in GRN carriers 10.4 years before the onset of the symptoms (standard difference 0.85, CI 0.01-1.68). DISCUSSION: FTD-GRN affects the brain hemispheres asymmetrically and causes 2 anatomical asymmetry patterns depending on the side of the disease onset. We demonstrated that these 2 anatomical asymmetry patterns present different symptoms, severity at the time of the first visit, and different disease courses. Our results also suggest brain asymmetry as a possible biomarker of conversion in GRN carriers.
引用
- Borrego-Ecija S, Juncà-Parella J, Vandebergh M, et al. Association of Initial Side of Brain Atrophy With Clinical Features and Disease Progression in Patients With GRN Frontotemporal Dementia. Neurology. 2024. PMID: 39527772. doi:10.1212/WNL.0000000000209944
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。